Speakers

Alexander Scheer

Chief Scientific Officer

Aelin Therapeutics

Guido Koch

Chief Executive Officer

Amphilix AG

Ian Churcher

Chief Scientific Officer

Amphista Therapeutics

Georg Winter

Principal Investigator

CeMM Research Centre for Molecular Medicine

Laura Luh

Research Scientist

Bayer AG

Thomas Hayhow

Medicinal Chemist

AstraZeneca

Bomie Han

Research Advisor

Eli Lilly

Gustavo Gutierrez

Principal Scientist

Galápagos NV

Ivan Dikic

Director of Institute of Biochemistry II

Goethe University Frankfurt

Brenda Schulman

Director of Molecular Machines and Signaling & Acting Executive Director

Max Planck Institute of Biochemistry

Jin Li

Chairman & Chief Executive Officer

HitGen

John Harling

Senior Scientific Director of Medicinal Chemistry

GlaxoSmithKline

Benedict Cross

Chief Technology Officer

PhoreMost

Danette Daniels

Group Leader of Functional Proteomics

Promega

Paul Thompson

Chief Scientific Officer

Mission Therapeutics

James Wilkinson

Sales Director

Refeyn

Simon Bailey

Executive Vice President & Head of Drug Discovery

Plexium

Tom Coulter

Director of Integrated Drug Discovery

Selvita

Agustina Rodriguez-Granillo

Principal Scientist II

Schrodinger

David Rubinsztein

Professor of Molecular Neurogenetics & UK Dementia Research Institute

University of Cambridge

Terry Rabbitts

Professor of Molecular Immunology

The Institute of Cancer Research

Alessio Ciulli

Professor of Chemical Structural Biology

University of Dundee

Alex Bullock

Associate Professor

University of Oxford

Elmar Wolf

Professor

University of Würzburg

Gopal Sapkota

Principal Investigator

University of Dundee